Jiangsu Lanfeng Bio-chemical Co.,Ltd

Shenzhen Stock Exchange 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA for the year ending December 31, 2023: USD -32.04 M

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA is USD -32.04 M for the year ending December 31, 2023, a -62.39% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA for the year ending December 31, 2022 was USD -19.73 M, a 68.28% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA for the year ending December 31, 2021 was USD -62.21 M, a -354.44% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA for the year ending December 31, 2020 was USD 24.45 M, a 147.53% change year over year.
Jiangsu Lanfeng Bio-chemical Co.,Ltd EBITDA for the year ending December 31, 2019 was USD -51.44 M, a 49.39% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

Shenzhen Stock Exchange: 002513.SZ

Jiangsu Lanfeng Bio-chemical Co.,Ltd

CEO	Mr. Jun Xing
IPO Date	Dec. 3, 2010
Location	China
Headquarters	No. 1 Suhua Road
Employees	1,573
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers thiophanate-methyl, cyclohexazone, benomyl, and carbendazim. The company is based in Xinyi, China.

Key trends

Past 5 years